Patents Assigned to CBA Pharma, Inc.
  • Tetrandrine family pharmaceutical formulations and method
    Patent number: 10815243
    Abstract: Drug formulations, methods and their use in treatment of diseases using formulations of pure di-acid salts of tetrandrine family members, especially d-tetrandrine di-hydrochloride, combined with a pharmaceutical diluent or carrier.
    Type: Grant
    Filed: June 20, 2018
    Date of Patent: October 27, 2020
    Assignee: CBA Pharma, Inc.
    Inventor: Ron D. Carroll
  • TETRANDRINE FAMILY PHARMACEUTICAL FORMULATIONS AND METHOD
    Publication number: 20180298022
    Abstract: Drug formulations, methods and their use in treatment of diseases using formulations of pure di-acid salts of tetrandrine family members, especially d-tetrandrine di-hydrochloride, combined with a pharmaceutical diluent or carrier.
    Type: Application
    Filed: June 20, 2018
    Publication date: October 18, 2018
    Applicant: CBA Pharma, Inc.
    Inventor: Ron D. Carroll
  • Tetrandrine family pharmaceutical formulations and method
    Patent number: 10023584
    Abstract: Drug formulations, methods and their use in treatment of diseases using formulations of pure di-acid salts of tetrandrine family members, especially d-tetrandrine di-hydrochloride, combined with a pharmaceutical diluent or carrier.
    Type: Grant
    Filed: November 8, 2016
    Date of Patent: July 17, 2018
    Assignee: CBA Pharma, Inc.
    Inventor: Ron D. Carroll
  • TETRANDRINE FAMILY PHARMACEUTICAL FORMULATIONS AND METHOD
    Publication number: 20170050975
    Abstract: Drug formulations, methods and their use in treatment of diseases using formulations of pure di-acid salts of tetrandrine family members, especially d-tetrandrine di-hydrochloride, combined with a pharmaceutical diluent or carrier.
    Type: Application
    Filed: November 8, 2016
    Publication date: February 23, 2017
    Applicant: CBA Pharma, Inc.
    Inventor: Ron D. Carroll
  • TETRANDRINE FAMILY PHARMACEUTICAL FORMULATIONS AND METHOD
    Publication number: 20170050976
    Abstract: Drug formulations, methods and their use in treatment of diseases using formulations of pure di-acid salts of tetrandrine family members, especially d-tetrandrine di-hydrochloride, combined with a pharmaceutical diluent or carrier.
    Type: Application
    Filed: November 8, 2016
    Publication date: February 23, 2017
    Applicant: CBA Pharma, Inc.
    Inventor: Ron D. Carroll
  • Tetrandrine family pharmaceutical formulations and method
    Patent number: 9517234
    Abstract: Drug formulations, methods and their use in treatment of diseases using formulations of pure di-acid salts of tetrandrine family members, especially d-tetrandrine di-hydrochloride, combined with a pharmaceutical diluent or carrier.
    Type: Grant
    Filed: March 6, 2014
    Date of Patent: December 13, 2016
    Assignee: CBA Pharma, Inc.
    Inventor: Ron D. Carroll
  • Method and products for enhancing drug and dietary supplement bioavailability
    Patent number: 9345257
    Abstract: Enhancing the bioavailability of a drug or dietary supplement by administering it concurrently with one or more members of the d-tetrandrine family.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: May 24, 2016
    Assignee: CBA Pharma, Inc.
    Inventor: Daryl L. Barnett
  • Tetrandrine pharmaceutical formulations
    Patent number: 9259420
    Abstract: Drug formulations, methods and their use in treatment of diseases using the free base formulations of tetrandrine family members, especially d-tetrandrine, combined with a pharmaceutical diluent or carrier.
    Type: Grant
    Filed: September 12, 2013
    Date of Patent: February 16, 2016
    Assignee: CBA Pharma, Inc.
    Inventor: Ron D. Carroll
  • Method and products for enhancing cellular uptake of drug and dietary supplements
    Patent number: 9254323
    Abstract: Enhancing the cellular uptake of a drug or dietary supplement by administering it concurrently with one or more members of the d-tetrandrine family.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: February 9, 2016
    Assignee: CBA Pharma, Inc.
    Inventor: Daryl L. Barnett
  • SUPERCRITICAL FLUID EXTRACTION OF BIS-BENZYL ISOQUINOLINES
    Publication number: 20150073151
    Abstract: An improved process for obtaining at least one bis-benzyl isoquinoline alkaloid from botanical material involves contacting the botanical material with a supercritical fluid having as a major component one or more aliphatic hydrocarbon compounds, such as alkanes, alkenes, cyclic aliphatic hydrocarbons, or a combination of these compounds.
    Type: Application
    Filed: March 12, 2014
    Publication date: March 12, 2015
    Applicant: CBA Pharma, Inc.
    Inventors: Beth D. Gudeman, Ram Murty
  • TETRANDRINE FAMILY PHARMACEUTICAL FORMULATIONS AND METHOD
    Publication number: 20140275137
    Abstract: Drug formulations, methods and their use in treatment of diseases using formulations of pure di-acid salts of tetrandrine family members, especially d-tetrandrine di-hydrochloride, combined with a pharmaceutical diluent or carrier.
    Type: Application
    Filed: March 6, 2014
    Publication date: September 18, 2014
    Applicant: CBA Pharma, Inc.
    Inventor: Ron D. Carroll
  • METHOD AND PRODUCTS FOR ENHANCING CELLULAR UPTAKE OF DRUG AND DIETARY SUPPLEMENTS
    Publication number: 20140275157
    Abstract: Enhancing the cellular uptake of a drug or dietary supplement by administering it concurrently with one or more members of the d-tetrandrine family.
    Type: Application
    Filed: March 12, 2014
    Publication date: September 18, 2014
    Applicant: CBA Pharma, Inc.
    Inventor: Daryl L. Barnett
  • METHOD AND PRODUCTS FOR ENHANCING DRUG AND DIETARY SUPPLEMENT BIOAVAILABILITY
    Publication number: 20140275140
    Abstract: Enhancing the bioavailability of a drug or dietary supplement by administering it concurrently with one or more members of the d-tetrandrine family.
    Type: Application
    Filed: March 12, 2014
    Publication date: September 18, 2014
    Applicant: CBA Pharma, Inc.
    Inventor: Daryl L. Barnett
  • METHOD AND PRODUCTS FOR TREATING DIABETES
    Publication number: 20140275138
    Abstract: Treating diabetes by administering one or more members of the d-tetrandrine family, either alone or with other Type 2 diabetes drugs or dietary supplements which mediate diabetes.
    Type: Application
    Filed: March 11, 2014
    Publication date: September 18, 2014
    Applicant: CBA Pharma, Inc.
    Inventor: James A. Mitchell
  • TETRANDRINE PHARMACEUTICAL FORMULATIONS AND METHOD
    Publication number: 20140135354
    Abstract: Drug formulations, methods and their use in treatment of diseases using the free base formulations of tetrandrine family members, especially d-tetrandrine, combined with a pharmaceutical diluent or carrier.
    Type: Application
    Filed: September 12, 2013
    Publication date: May 15, 2014
    Applicant: CBA Pharma, Inc.
    Inventor: Ron D. Carroll
  • MDR METHOD AND PRODUCTS FOR TREATING MRSA
    Publication number: 20140073591
    Abstract: Multidrug resistance reversers of the d-tetrandrine family are used in conjunction with penicillins and other principle drugs used to treat MRSA.
    Type: Application
    Filed: September 12, 2013
    Publication date: March 13, 2014
    Applicant: CBA Pharma, Inc.
    Inventors: Wayne Michael Putnam, Beth D. Gudeman
  • Method for extracting and purifying bisbenzylisoquinolines
    Patent number: 8609844
    Abstract: A method for purifying extracted crude d-tetrandrine by dissolving the crude d-tetrandrine powder in ethanol, treating the solution with a decolorizing agent, filtering, reducing the filtered solution under heat and vacuum, cooling the solution, filtering it and drying the filtered cake to yield substantially pure d-tetrandrine.
    Type: Grant
    Filed: November 4, 2010
    Date of Patent: December 17, 2013
    Assignee: CBA Pharma, Inc.
    Inventor: Ron D. Carroll